Priser
Platform
Blog
Om os
Download
000939
Kaidi Ecological and Environmental Technology Co
Shenzhen Stock Exchange (Hong Kong)

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I KAIDI ECOLOGICAL AND ENVIRONMENTAL TECHNOLOGY CO MED ENDAVU: Køb Kaidi Ecological and Environmental Technology Co ($000939) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Kaidi Ecological and Environmental Technology Co, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

Ticker1752
Land
Taiwan
Hjemmesidenangkuang.com.tw
SektorSundhed
IndustriMedicinske instrumenter og forsyninger

Om

Nang Kuang Pharmaceutical Co., Ltd. operates as a prominent entity within the pharmaceutical industry, specializing in the development, manufacturing, and sale of health-focused products. The company plays a vital role in the healthcare sector by producing a wide range of pharmaceuticals, including prescription drugs, over-the-counter medications, and biopharmaceuticals. It is known for its commitment to research and development, consistently striving to enhance its product offerings and address various therapeutic needs. Nang Kuang Pharmaceutical significantly impacts both domestic and international markets by exporting its high-quality products across the globe. Its operations support critical health infrastructures and contribute to the availability of essential medicine in various regions, reinforcing its importance in the global pharmaceutical supply chain. With a focus on innovation and quality, Nang Kuang Pharmaceutical Co., Ltd. remains a key player in addressing evolving healthcare challenges and requirements.

Udbytter

1,6TWD
'21
1,8TWD
'22
2,3TWD
'23
2TWD
'24
1,6TWD
'25
1,6TWD
'26
Ex-udbytte-dato2. jul. 2026
Udbytteafkast5,08%